PubReading [157] - Cell-SELEX Technology - S. Ohuchi episode artwork

EPISODE · Jun 30, 2022 · 29 MIN

PubReading [157] - Cell-SELEX Technology - S. Ohuchi

from PubReading

Aptamers are molecules identified from large combinatorial nucleic acid libraries by their high affinity to target molecules. Due to a variety of desired properties, aptamers are attractive alternatives to antibodies in molecular biology and medical applications. Aptamers are identified through an iterative selection–amplification process known as systematic evolution of ligands by exponential enrichment (SELEX). Although SELEX is typically carried out using purified target molecules, whole live cells are also employable as selection targets. This technology, Cell-SELEX, has several advantages. For example, generated aptamers are functional with a native conformation of the target molecule on live cells, and thus, cell surface transmembrane proteins would be targets even went their purifications in native conformations are difficult. In addition, cell-specific aptamers can be obtained without any knowledge about cell surface molecules on the target cells. Here, I review the progress of Cell-SELEX technology and discuss advantages of the technologyDOI: 10.1089/biores.2012.0253265 - 2012

Episode metadata supplied by the publisher feed · Published Jun 30, 2022

Embed this episode

NOW PLAYING

PubReading [157] - Cell-SELEX Technology - S. Ohuchi

0:00 29:13

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of PubReading?

This episode is 29 minutes long.

When was this PubReading episode published?

This episode was published on June 30, 2022.

Can I download this PubReading episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!